Anti-PD-1 antibodies: immune-related adverse events and efficacy

被引：0
|
作者：
机构：
来源：
Reactions Weekly | 2019年 / 1739卷 / 1期
关键词：
D O I：
10.1007/s40278-019-57646-9
中图分类号：
学科分类号：
摘要：
引用
下载
收藏
页码：6 / 6
相关论文
共 50 条
  • [1] Immune-related adverse events predict the therapeutic efficacy of anti-PD-1 antibodies in cancer patients
    Rogado, J.
    Sanchez-Torres, J. M.
    Romero-Laorden, N.
    Ballesteros, A., I
    Pacheco-Barcia, V
    Ramos-Levi, A.
    Arranz, R.
    Lorenzo, A.
    Gullon, P.
    Donnay, O.
    Adrados, M.
    Costas, P.
    Aspa, J.
    Alfranca, A.
    Mondejar, R.
    Colomer, R.
    EUROPEAN JOURNAL OF CANCER, 2019, 109 : 21 - 27
  • [2] Effect of excess weight and immune-related adverse events on the efficacy of cancer immunotherapy with anti-PD-1 antibodies
    Rogado, Jacobo
    Romero-Laorden, Nuria
    Miguel Sanchez-Torres, Jose
    Maria Ramos-Levi, Ana
    Pacheco-Barcia, Vilma
    Isabel Ballesteros, Ana
    Arranz, Reyes
    Lorenzo, Alicia
    Gullon, Pedro
    Garrido, Ana
    Serra Lopez-Matencio, Jose Maria
    Donnay, Olga
    Adrados, Magdalena
    Costas, Pablo
    Aspa, Javier
    Alfranca, Arantzazu
    Mondejar, Rebeca
    Colomer, Ramon
    ONCOIMMUNOLOGY, 2020, 9 (01):
  • [3] Immune-related adverse events with resumed anti-PD-1 therapy
    Reactions Weekly, 2017, 1676 (1) : 4 - 4
  • [4] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Eun, Yeonghee
    Kim, In Young
    Sun, Jong-Mu
    Lee, Jeeyun
    Cha, Hoon-Suk
    Koh, Eun-Mi
    Kim, Hyungjin
    Lee, Jaejoon
    SCIENTIFIC REPORTS, 2019, 9 (1)
  • [5] Risk factors for immune-related adverse events associated with anti-PD-1 pembrolizumab
    Yeonghee Eun
    In Young Kim
    Jong-Mu Sun
    Jeeyun Lee
    Hoon-Suk Cha
    Eun-Mi Koh
    Hyungjin Kim
    Jaejoon Lee
    Scientific Reports, 9
  • [6] Association of efficacy of anti-PD-1 immunotherapy in patients with advanced cancer with immune-related adverse events (irAEs)
    Rogado Revuelta, Jacobo
    Romero-Laorden, Nuria
    Sanchez Torres, Jose Miguel
    Pacheco-Barcia, Vilma
    Ballesteros, Anabel
    Maria Ramos-Levi, Ana
    Arranz, Reyes
    Lorenzo, Alicia
    Gullon, Pedro
    Garrido Garcia, Ana
    Maria Serra, Jose
    Donnay, Olga
    Adrados, Magdalena
    Costas, Pablo
    Aspa, Javier
    Alfranca, Arantza
    Fenor De la Maza, Maria Dolores
    Mondejar, Rebeca
    Colomer, Ramon
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [7] Immune-related adverse events (irAEs) predict therapeutic efficacy of an anti-PD-1 antibody in cancer patients
    Rogado, J.
    Romero Laorden, N.
    Sanchez Torres, J. M.
    Ballesteros Garcia, A. I.
    Pacheco-Barcia, V. E.
    Arranz, R.
    Mondejar Solis, R.
    Gullon, P.
    Lorenzo, A.
    Colomer Bosch, R.
    ANNALS OF ONCOLOGY, 2018, 29
  • [8] Immune-related adverse events of anti-PD-1 immune checkpoint inhibitors: a single center experience
    Sebestyen, Eniko
    Major, Nora
    Bodoki, Levente
    Makai, Attila
    Balogh, Ingrid
    Toth, Gabor
    Orosz, Zsuzsanna
    Arkosy, Peter
    Vasko, Attila
    Hodosi, Katalin
    Szekanecz, Zoltan
    Szekanecz, Eva
    FRONTIERS IN ONCOLOGY, 2023, 13
  • [9] Immune-related adverse event recurrence with anti-PD-1 therapy
    Reactions Weekly, 2020, 1816 (1) : 8 - 8
  • [10] Immune-related adverse events in a patient with eosinophilic enteritis treated with immune checkpoint inhibitors (anti-PD-1)
    Cybulska-Stopa, Bozena
    Kaminska-Winciorek, Grazyna
    Dyduch, Grzegorz
    MELANOMA RESEARCH, 2020, 30 (06) : 619 - 624
12345